Latest News

C360 Spine Portfolio Unveiled -NuVasive Advises Launch Represents a Significant Opportunity for Growth As Cervical Spine Procedures Comprise An Approximately $2.6 Bil Segment of the Global Spine Market

"C360 spine portfolio unveiling reflects NuVasive's commitment to deliver innovative technology for the anterior and posterior cervical spine designed to improve the quality of care even in the most established area of spine," said Massimo Calafiore, executive vice president, Global Business Units at NuVasive.

Novel Biosynthetic Tissue Valve 6 Month Clinical Results Reported

Six-month data for 16 patients enrolled across three sites in the United States were presented in a moderated poster session during the American Heart Association Virtual Scientific Sessions from November 13-17, 2020. The poster, P148, is titled, Early Results of a Novel ePTFE-based Pulmonary Valved Conduit in a Pediatric Patient Population.

Retinal-imaging Breakthrough That Can Swiftly Detect Eye Diseases

European researchers are developing a new real-time scanner that will create a full image of a moving eye without any blurring. Teaming up with photonics innovation hub ACTPHAST 4R the scientists at Vrije Universiteit (VU) Amsterdam are progressing their scanner concept to a demonstrator stage to acquire data faster than existing optical imaging technologies.  

Hologic Showcases Products at Virtual RSNA 2020

Company will virtually showcase its extensive portfolio of breast and skeletal health products, including screening, surgical, interventional, ultrasound, and skeletal solutions, at the 106th Scientific Assembly and Annual Meeting of the RSNA from Nov. 29 to Dec. 5.

United States Blood Glucose Meter Market Insights Report 2020-2027

United States Blood Glucose Meter Market Insights Report – The United States market for the blood glucose meter is primarily expected to be driven during the forecast period by the large patient pool suffering from diabetes and the rapid uptake of innovative, user-friendly, and technological advancements products.

The United States Blood Glucose Meter Market Insights Report 2020 – 2027 presents an in-depth assessment of the United States blood glucose meter market dynamics, opportunities, future roadmap, competitive outlook and discusses foremost trends. The report gives the most up-to-date industry statistics at the real marketplace situation and future outlook in the United States blood glucose meter market. The report includes historical data from 2015 to 2019 and forecasts until 2027.

The report contains a granular evaluation of the present industry conditions, market demands, reveal facts on the market size, revenues, and provides forecasts through 2027. The report provides a clear insight into modern-day and future traits of the United States blood glucose meter market. The report provides a decisive view of the United States blood glucose meter users’ volume and market size.

The report additionally provides an all-round analysis of an overall number of patients with diabetes and insulin users in the United States. Moreover, the report consists of an assessment of reimbursement patterns and offers a clear view of the regulatory landscape of the blood glucose meter in the United States. Key trends in terms of collaboration, partnerships, mergers & acquisitions, distribution, exclusive, and licensing agreements are analyzed with details. The report also explores the exhaustive description of growth drivers and inhibitors of the United States blood glucose meter market.

The report concludes with the profiles of key players in the United States blood glucose meter market. The key market players are evaluated on various parameters such as business overview, key marketed products with pricing, and current development.

Report Scope:

  • Market Size of the United States Blood Glucose Meter Market with Seven Years Forecast
  • Detailed Assessment of the United States Blood Glucose Meter Users Volume and Forecast to 2027
  • Complete Overview of the United States Insulin Users and Forecast to 2027
  • An Insightful Analysis of the United States Diabetes Population and Forecast to 2027
  • Investigates the Key Growth Drivers and Restraints of the United States Blood Glucose Meter Market
  • Provides Key Trends with Respect to Collaboration Deals, Mergers & Acquisitions, Distribution Agreement, Exclusive Agreement, Partnership Deals, and Licensing Agreement
  • Detailed Insights into the Regulatory Framework of the United States Blood Glucose Meter Market
  • Features Reimbursement Patterns of the United States Blood Glucose Meter Market
  • A Comprehensive List of Key Market Players Along with the Analysis of their Current Blood Glucose Meter Portfolios, Business Overview, and Current Development

The Report Helps Answer the Following Questions:

  • How many people in the United States have diabetes?
  • How many people in the United States use insulin?
  • What is the current size of the United States blood glucose meter market? How much will this market be worth from 2020 to 2027?
  • What are the main drivers and restraints in the United States blood glucose meter market?
  • What are the major deals happenings in the United States blood glucose meter market?
  • What are the various blood glucose meter available in the United States?
  • What are the reimbursement policies of the blood glucose meter in the United States?
  • What is the regulatory system of the blood glucose meter in the United States?
  • How will the industry evolve during the forecast period 2020 – 2027?
  • Who are the top market players and what are their happenings, products, current developments, and scenarios? 

Key Topics Covered:

1. Executive Summary

2. United States Diabetes Population and Forecast, 2015 – 2027

3. United States Insulin Users Volume and Forecast, 2015 – 2027

4. United States Blood Glucose Meter Users Volume Assessment and Forecast, 2015 – 2027

5. United States Blood Glucose Meters Market Analysis, Insights and Forecast, 2015 – 2027

6. Key Market Drivers and Inhibitors of the United States Blood Glucose Meter Market

7. Reimbursement Environment of the United States Blood Glucose Meter Market

8. Regulatory Framework of the United States Blood Glucose Meter Market

9. Recent Industry Developments and Deals in the Blood Glucose Meter Market

10. Key Companies Profiles (Overview, Key Marketed Products, and Recent Development)

  • Abbott Diabetes Care
  • AgaMatrix
  • Arkray, Inc
  • Ascensia Diabetes Care
  • BioTel Care
  • Dario Health
  • Entra Health (Acquired by CRF Health)
  • Fifty50 Medical
  • ForaCare
  • Genesis Health Technologies
  • iHealth Labs
  • LifeScan, Inc
  • Livongo Health
  • Nova Diabetes Care
  • Oak Tree Health
  • Omnis Health
  • One Drop
  • Prodigy Diabetes Care, LLC
  • Roche
  • Sanofi
  • Simple Diagnostics
  • Smart Meter LLC
  • Trividia Health, Inc
  • U.S. Diagnostics
  • Walgreens

For more information about this report visit here.

Latest Posts

C360 Spine Portfolio Unveiled -NuVasive Advises Launch Represents a Significant Opportunity for Growth As Cervical Spine Procedures Comprise An Approximately $2.6 Bil Segment of the Global Spine Market

"C360 spine portfolio unveiling reflects NuVasive's commitment to deliver innovative technology for the anterior and posterior cervical spine designed to improve the quality of care even in the most established area of spine," said Massimo Calafiore, executive vice president, Global Business Units at NuVasive.

LuminUltra Acquires Source Molecular Corporation – To Expands Testing Capacity Including Range of COVID-19 Offerings

LuminUltra has acquired Source Molecular Corporation, a leader in lab-based testing solutions for microbial source tracking of pathogens including SARS-CoV-2, the virus that causes COVID-19.

MapLight Therapeutics Receives $8.1 Million For Parkinson’s Disease Research

The company will use the funds to undertake a large-scale, systematic investigation of the brain circuits and mechanisms that are responsible for triggering psychiatric symptoms in Parkinson's disease.

Novel Biosynthetic Tissue Valve 6 Month Clinical Results Reported

Six-month data for 16 patients enrolled across three sites in the United States were presented in a moderated poster session during the American Heart Association Virtual Scientific Sessions from November 13-17, 2020. The poster, P148, is titled, Early Results of a Novel ePTFE-based Pulmonary Valved Conduit in a Pediatric Patient Population.

Don't Miss

Genetron Health Provides Update on HCCscreen™ for Liver Cancer Early Screening in China

Establishes joint venture with Wuxi municipal government; Expects the commercialization and revenues of HCCscreen to accelerate in China.

Research Paper Showing ProtoKinetix AAGP® Enhanced Stem Cell Derived Retina Precursor Cells Restoration of Vision

ProtoKinetix notes the research paper has been submitted to a prestigious journal specializing in tissue regeneration for peer review and editing.

OrganaBio to Expand Its cGMP Cell and Gene Therapy Manufacturing Facility: 19,000 Sq. Ft. Slated to Commence Operations In Q3 2021

OrganBio, a Miami-based cGMP facility, will include process development space, ISO 7 cleanrooms, state-of-the-art scientific equipment, analytics and QC laboratories, and a suite of support services to enable OrganaBio and its partners to rapidly and economically self-manufacture clinical materials. 

Stoke Therapeutics Announces Proposed Public Offering

November 18, 2020 Stoke Therapeutics, Inc., a biotechnology company pioneering a new way to treat the underlying cause of genetic diseases by precisely upregulating protein...

TissueCypher Barrett’s Esophagus Assay Confirm the Ability to Identify Patients at High Risk for Progression to Cancer

TissueCypher Barrett’s Esophagus Assay independent peer-reviewed studies, are authored by Prof. Jacques Bergman and Dr. Nicola Frei (University Medical Center, Amsterdam, the Netherlands).